| Rodolfo Paoletti, P.G. Crosignani, P. Kenemans, N.K. Wenger, Ann S. Jackson - 2007 - 292 páginas
...progestogen intolerance. Maturitas 1994; 18:87-91. 11. Hosking D, Chilvers CED, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338:485-92. 12. Thiebaud D, Burckhardt P, Kriegbaum H. et al. Three monthly intravenous... | |
| Margaret Urban Walker - 1999 - 308 páginas
...D. Thompson, M. Daley, and AJ Yates, for the Early Postmenopausal Intervention Cohort Study Group, "Prevention of Bone Loss with Alendronate in Postmenopausal Women Under 60 Years of Age," New England Journal of Medicine 338 (1998): 485-92. Fosamax was approved in the United States by the... | |
| Sarah H. Gueldner, Theresa N. Grabo, Eric D. Newman MD, David R. Cooper MD, AAOS - 2007 - 220 páginas
...C., Ravn, P., Wasnich, R., Ross, P., McClung. M., Balske, A., Thompson, D., Daley, M., & Yates, AJ (1998). Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. New England Journal of Medicine, 338, 485-492. Huddleston, AL, Rockwell, D., Kulund, DN, & Harrison,... | |
| Herbert Fleisch - 2000 - 225 páginas
...C., Ravn, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., and Yates, J. (1998). Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N. Engl. J. Med., 338,485-493 Khan, SA, Kanis, JA, Vasikaran, S., Kline, WF, Matuszewski, BK, McCloskey,... | |
| William J. Gradishar, William C. Wood - 2000 - 230 páginas
...without osteoporosis. Ann Intern Med.1998; 128:253. 44. Hosking D, Chilvers CE, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998; 338:485. 45. Grady D , Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease... | |
| Karl Obrant - 2000 - 630 páginas
...vertebral fractures. Lancet 1996;348: 1535- 1541. 36. Hosking D, Chilvers CED, Christiansen C, et al. Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998;338: 485-492. 37. Cummings SR, Black DM, Thompson DE, et al. Effect of alendronate... | |
| Robert E.C. Wildman, Denis M. Medeiros - 1999 - 612 páginas
...McClung, M., Blaske, A., Thompson, D., Daley, M., and Yates, AJ, Prevention of bone loss with aldronate in postmenopausal women under 60 years of age. Early postmenopausal Intervention Cohort Study Group, N. Engl. /. Med., 338(8), 485-492, 1998. Looker, AC, Orwell, ES, Johnston, CC, Lindsay, RL, Warmer,... | |
| E. Margaria, E. Gollo - 2001 - 504 páginas
...post menopausal women. Am ) Obstet Gynecol 161:1842-1846 8. Hosking D, Chilvers CE, Christiansen C et al (1998) Prevention of bone loss with alendronate...Early Postmenopausal Intervention Cohort Study Group. N Engl J Med 338(8):485-492 9. Delmas PD, Bjarnason NH.Mitlak BH et al (1997) Effects of raloxifene... | |
| Derek Pearson - 2002 - 280 páginas
...year of open therapy. Am J Med 1993;95:557-67. 44. Hosking DJ, Chilvers CED, Christiansen C et al. Prevention of bone loss with Alendronate in postmenopausal women under 60 years of age. N Engl J Med 1998^338:485-92. 45. Seeman E, Delmas PD. Reconstructing the skeleton with intermittent... | |
| Jay Schulkin - 2003 - 332 páginas
...C., Raun, P., Wasnich, R., Ross, P., McClung, M., Balske, A., Thompson, D., Daley, M., and Yates, AJ (1998). Prevention of bone loss with alendronate in...Early postmenopausal intervention cohort study group. N. Engl. }. Med. 338: 485-492. Housknecht, KL, and Portocarrero, CP (1998). Leptin and its receptors:... | |
| |